










































































Figure 1: Plasmacytoid dendritic cell and associated lupus pathways (1) 
Figure 2: Cre recombinase methods of use (2) 
Figure 3: IFNAR flx/flx kidney 
samples taken at 9 months 
Figure 4: IFNAR +/+ kidney 
samples taken at 9 months 
Figure 5: IFNAR flx/flx kidney 
samples taken at 9 months 
Figure 6: IFNAR f+/+ kidney 
samples taken at 9 months 
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